What is molybdenum breakthrough in a Tc-99m generator?
Molybdenum breakthrough refers to the presence of molybdenum-99 (Mo-99) in the Tc-99m eluate from a radionuclide generator. Ideally, Mo-99 remains bound to the alumina column within the generator, while only Tc-99m is eluted. If Mo-99 appears in the eluate, this represents a failure of radionuclidic purity.
Molybdenum breakthrough is the contamination of Tc-99m eluate with Mo-99, increasing radiation dose and representing a failure of radionuclidic purity.
Because Mo-99 has a longer half-life and emits higher-energy radiation than Tc-99m, its presence increases patient radiation dose and may degrade image quality. For this reason, strict regulatory limits are placed on allowable Mo-99 contamination.
Understanding the physics
A Tc-99m generator contains Mo-99 adsorbed onto an alumina (aluminium oxide) column. Mo-99 decays to Tc-99m, which forms as pertechnetate (TcO₄⁻) and can be eluted using saline.
Under normal conditions:
Mo-99 remains tightly bound to the alumina column.
Tc-99m is washed off during elution.
However, if the column integrity is compromised, small amounts of Mo-99 may be washed into the eluate. This is known as molybdenum breakthrough.
Mo-99 decays by beta emission and produces higher-energy gamma photons than Tc-99m. Unlike aluminium breakthrough, which is a chemical impurity, molybdenum breakthrough represents contamination by a different radioactive isotope.
The regulatory limit is typically expressed as the fraction of Mo-99 activity relative to Tc-99m activity at the time of administration (commonly ≤0.1%). Because Mo-99 has a much longer half-life (about 66 hours compared with 6 hours for Tc-99m), its relative contribution to patient dose can become significant if present in excess.
Testing for Mo breakthrough is performed using a dose calibrator with appropriate shielding to detect higher-energy emissions.
Where this matters clinically
Excess Mo-99 increases patient radiation exposure and may introduce unwanted high-energy photons that degrade image quality. Routine quality control testing ensures that eluate meets safety standards before administration.
Understanding molybdenum breakthrough reinforces the distinction between radionuclidic purity (correct isotope) and radiochemical purity (correct chemical form).